Delivery Order SPE2DB22D2007-SPE2DB25FJ4FE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,063.52 to AmerisourceBergen Drug Corp for the supply of Bupropion HCL XL 150 mg tablets in quantities of 500 units. This contract, which was awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- On August 14, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Bupropion HCL XL 150 mg tablets (100 unit dose packages) with a ceiling value of $2,472.49. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 15, 2025, and performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $1,814.29, is for the supply of Bupropion HCL XL 300 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Bupropion HCL 100 mg tablets in quantities of 100 units, with a contract value of $1,611.42. The award was made on August 21, 2025, with an ultimate completion date of August 22, 2025, and utilized firm fixed-price pricing with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency Troop Support Medical awarded a $193.95 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4562229746 Bupropion HCL XL 300 MG tablets. As the prime contractor, Amerisourcebergen Drug will deliver 90 tablets to a location in Conshohocken, Pennsylvania under a one-day period of performance from September 20-21, 2023. The Defense Logistics Agency facilitates the delivery of medical supplies and equipment to support Department of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,981,495 units of Bupropion HCl XL 300 mg tablets. The $3,363.79 contract has a period of performance through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 500 tablets of Bupropion HCL XL 150 mg. The contract has a total potential value of $2,209.29 and a completion date of February 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The delivery order, valued at $12,723.06, is for the supply of 4,564,083,598 units of Bupropion HCL XL 150 mg tablets to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order falls under a larger indefinite delivery contract (IDC) awarded...
- The Defense Logistics Agency awarded a delivery order valued at $2,714.16 to AmerisourceBergen Drug Corp for Wellbutrin XL 150 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The place of...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $28,560 to Amerisourcebergen Drug Corporation for the supply of 4561731839 Bupropion HCL XL 150 mg tablets. Under this single award, Amerisourcebergen will deliver 90 tablets to a facility located in Conshohocken, Pennsylvania, with performance required from August 7-8, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order supports the DLA's stockpile needs and...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4FEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,483.78 to AmerisourceBergen Drug Corp for 500 tablets of Bupropion HCL XL 300 mg on August 21, 2025, with completion scheduled for August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed under a competitive award process. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary distribution hub for federal pharmaceutical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies comprehensive pharmaceutical products and medical supplies to support military healthcare systems and other government agencies worldwide. The company's extensive contract portfolio demonstrates its capability to efficiently fulfill federal medical supply requirements across multiple therapeutic domains, and this bupropion order represents a routine deployment of resources under its prime vendor contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 8/21/25 |